3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide

C158H154N38O10S6 — CID 158940746

About 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide

3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide (PubChem CID 158940746) has the molecular formula C158H154N38O10S6 and a molecular weight of 2937.63 g/mol. Its IUPAC name is 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide.

Molecular Properties

• Compound Name: 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide
• PubChem CID: 158940746
• Molecular Formula: C158H154N38O10S6
• Molecular Weight: 2937.63 g/mol
• Exact Mass: 2935.10
• IUPAC Name: 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide
• SMILES: CN(C)[C@H]1CCc2nc(NC(=O)c3cccc(CN4CCN(c5ccc(C#N)cc5)C4=O)c3)sc2C1.CN(C)[C@H]1CCc2nc(NC(=O)c3cccc(Cn4cc(-c5ccc(C#N)cc5)cn4)c3)sc2C1.CN(C)[C@H]1CCc2nc(NC(=O)c3cccc(Cn4cc(-c5ccc(C#N)cc5)nn4)c3)sc2C1.CN1CCc2nc(NC(=O)c3cccc(CN4CCN(c5ccc(C#N)cc5)C4=O)c3)sc2C1.CN1CCc2nc(NC(=O)c3cccc(Cn4cc(-c5ccc(C#N)cc5)nn4)c3)sc2C1.N#Cc1ccc(N2CCN(Cc3cccc(C(=O)Nc4nc5c(s4)C[C@@H](N4CCOCC4)CC5)c3)C2=O)cc1
• InChI: InChI=1S/C29H30N6O3S.C27H28N6O2S.C27H26N6OS.C26H25N7OS.C25H24N6O2S.C24H21N7OS/c30-18-20-4-6-23(7-5-20)35-11-10-34(29(35)37)19-21-2-1-3-22(16-21)27(36)32-28-31-25-9-8-24(17-26(25)39-28)33-12-14-38-15-13-33;1-31(2)22-10-11-23-24(15-22)36-26(29-23)30-25(34)20-5-3-4-19(14-20)17-32-12-13-33(27(32)35)21-8-6-18(16-28)7-9-21;1-32(2)23-10-11-24-25(13-23)35-27(30-24)31-26(34)21-5-3-4-19(12-21)16-33-17-22(15-29-33)20-8-6-18(14-28)7-9-20;1-32(2)21-10-11-22-24(13-21)35-26(28-22)29-25(34)20-5-3-4-18(12-20)15-33-16-23(30-31-33)19-8-6-17(14-27)7-9-19;1-29-10-9-21-22(16-29)34-24(27-21)28-23(32)19-4-2-3-18(13-19)15-30-11-12-31(25(30)33)20-7-5-17(14-26)6-8-20;1-30-10-9-20-22(15-30)33-24(26-20)27-23(32)19-4-2-3-17(11-19)13-31-14-21(28-29-31)18-7-5-16(12-25)6-8-18/h1-7,16,24H,8-15,17,19H2,(H,31,32,36);3-9,14,22H,10-13,15,17H2,1-2H3,(H,29,30,34);3-9,12,15,17,23H,10-11,13,16H2,1-2H3,(H,30,31,34);3-9,12,16,21H,10-11,13,15H2,1-2H3,(H,28,29,34);2-8,13H,9-12,15-16H2,1H3,(H,27,28,32);2-8,11,14H,9-10,13,15H2,1H3,(H,26,27,32)/t24-;22-;23-;21-;;/m0000../s1
• InChIKey: JKFFFGLWXURYIV-AWEPIOHKSA-N
• XLogP: 23.88
• TPSA: 573.24 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 42
• Rotatable Bonds: 34
• Heavy Atoms: 212
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2937.63
LogP ≤ 5	23.88
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	42

Frequently Asked Questions

What is the IUPAC name of 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide?

The IUPAC name of 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide (CID 158940746) is 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide.

What is the SMILES notation for 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide?

The canonical SMILES for 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide is CN(C)[C@H]1CCc2nc(NC(=O)c3cccc(CN4CCN(c5ccc(C#N)cc5)C4=O)c3)sc2C1.CN(C)[C@H]1CCc2nc(NC(=O)c3cccc(Cn4cc(-c5ccc(C#N)cc5)cn4)c3)sc2C1.CN(C)[C@H]1CCc2nc(NC(=O)c3cccc(Cn4cc(-c5ccc(C#N)cc5)nn4)c3)sc2C1.CN1CCc2nc(NC(=O)c3cccc(CN4CCN(c5ccc(C#N)cc5)C4=O)c3)sc2C1.CN1CCc2nc(NC(=O)c3cccc(Cn4cc(-c5ccc(C#N)cc5)nn4)c3)sc2C1.N#Cc1ccc(N2CCN(Cc3cccc(C(=O)Nc4nc5c(s4)C[C@@H](N4CCOCC4)CC5)c3)C2=O)cc1.

What is the InChIKey of 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide?

The InChIKey is JKFFFGLWXURYIV-AWEPIOHKSA-N. The full InChI is InChI=1S/C29H30N6O3S.C27H28N6O2S.C27H26N6OS.C26H25N7OS.C25H24N6O2S.C24H21N7OS/c30-18-20-4-6-23(7-5-20)35-11-10-34(29(35)37)19-21-2-1-3-22(16-21)27(36)32-28-31-25-9-8-24(17-26(25)39-28)33-12-14-38-15-13-33;1-31(2)22-10-11-23-24(15-22)36-26(29-23)30-25(34)20-5-3-4-19(14-20)17-32-12-13-33(27(32)35)21-8-6-18(16-28)7-9-21;1-32(2)23-10-11-24-25(13-23)35-27(30-24)31-26(34)21-5-3-4-19(12-21)16-33-17-22(15-29-33)20-8-6-18(14-28)7-9-20;1-32(2)21-10-11-22-24(13-21)35-26(28-22)29-25(34)20-5-3-4-18(12-20)15-33-16-23(30-31-33)19-8-6-17(14-27)7-9-19;1-29-10-9-21-22(16-29)34-24(27-21)28-23(32)19-4-2-3-18(13-19)15-30-11-12-31(25(30)33)20-7-5-17(14-26)6-8-20;1-30-10-9-20-22(15-30)33-24(26-20)27-23(32)19-4-2-3-17(11-19)13-31-14-21(28-29-31)18-7-5-16(12-25)6-8-18/h1-7,16,24H,8-15,17,19H2,(H,31,32,36);3-9,14,22H,10-13,15,17H2,1-2H3,(H,29,30,34);3-9,12,15,17,23H,10-11,13,16H2,1-2H3,(H,30,31,34);3-9,12,16,21H,10-11,13,15H2,1-2H3,(H,28,29,34);2-8,13H,9-12,15-16H2,1H3,(H,27,28,32);2-8,11,14H,9-10,13,15H2,1H3,(H,26,27,32)/t24-;22-;23-;21-;;/m0000../s1.

What are the key properties of 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide?

3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide has a molecular weight of 2937.63 g/mol, XLogP of 23.88, 34 rotatable bonds, 6 hydrogen bond donors, and 42 hydrogen bond acceptors.

Where does this data come from?

All data for 3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide;3-[[3-(4-cyanophenyl)-2-oxoimidazolidin-1-yl]methyl]-N-[(6S)-6-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)pyrazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;3-[[4-(4-cyanophenyl)triazol-1-yl]methyl]-N-(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl)benzamide is sourced from PubChem (CID 158940746), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).